LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 21, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Nutex Health Inc. ("Nutex†or the "Company†) (NASDAQ: NUTX) securities between August 8, 2024 and August 14, 2025, inclusive (the "Class Period†). IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUTEX HEALTH INC. (NUTX), CLICK HERE TO PARTICIPATE IN THE SECURIT. ...

NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline. SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the specified class period from August 8, 2024, to August 14, 2025 [8]. Allegation Details - The lawsuit claims that Nutex engaged in a scheme to defraud insurance companies through HaloMD, leading to unsustainable revenue [3]. - It is alleged that Nutex overstated its ability to remediate material weaknesses in its internal controls over financial reporting [3]. - The company reportedly misclassified stock-based compensation obligations, increasing the risk of failing to file timely financial reports with the SEC [3]. - Overall, the public statements made by Nutex were deemed materially false and misleading throughout the relevant period [3]. Next Steps - Investors who purchased Nutex shares and suffered losses are encouraged to contact the law firm for more information regarding their rights and potential claims [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 21, 2025 [8]. About the Law Firm - Bragar Eagel & Squire, P.C. is a nationally recognized law firm that represents individual and institutional investors in complex litigation [5].

Accessibility StatementSkip Navigation NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Nutex Health Inc. ("Nutex Health Inc." or the "Company") (NASDAQ: NUTX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Nutex Health Inc. investors who were adversely affected by alleged securities fraud between August 8, 2024 and August 14, 2025. Follow the link below to get more information and be contacted by a member of our te ...

Accessibility StatementSkip Navigation NUTX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Oct. 21, 2025 /PRNewswire/ -- Nutex Health Inc. (NASDAQ: NUTX), a publicly traded operator of micro-hospitals and healthcare facilities, is under legal scrutiny following a class-action lawsuit that accuses the company of orchestrating a deceptive billing strategy to artificially boost its financial results. The litigation, filed in a Texas federal court, alleges that Nutex collaborated with ...

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. on behalf of shareholders who purchased securities between August 8, 2024, and August 14, 2025, indicating potential legal challenges for the company [1]. Company Summary - Nutex Health Inc. is described as a "physician-led, healthcare services and operations company," highlighting its focus on healthcare delivery and management [1]. Legal Investigation - The Rosen Law Firm is investigating allegations related to the class action, which may impact the company's reputation and financial standing [1].

Core Viewpoint - Nutex Health Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between August 8, 2024, and August 14, 2025 [1][2]. Summary by Sections Class Action Details - The lawsuit aims to recover losses for investors affected by false statements and concealment of facts related to Nutex's financial practices [1]. - Allegations include that HaloMD, a third-party vendor, engaged in fraudulent activities that led to unsustainable revenue for Nutex [2]. - The company is accused of overstating its remediation of internal control weaknesses and improperly accounting for stock-based compensation obligations [2]. Next Steps for Investors - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require any out-of-pocket costs for class members [3]. Firm Background - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm is recognized as one of the top securities litigation firms in the United States, ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [4].

Core Viewpoint - Nutex Health Inc. is facing legal scrutiny due to a class-action lawsuit alleging deceptive billing practices that artificially inflated its financial results [1][2] Group 1: Legal Allegations - The lawsuit claims Nutex collaborated with HaloMD to submit ineligible insurance claims, misleading shareholders and causing significant financial losses [1][2] - Allegations include a systematic effort to exploit the insurance arbitration process, submitting thousands of questionable claims to extract outsized reimbursements [2][3] - The complaint argues that Nutex's revenue model is unstable and that financial statements misrepresented the company's operations [2] Group 2: Market Reaction - Following a report by activist short-seller Blue Orca Capital, Nutex shares dropped over 10%, reflecting investor concerns about the company's reliance on arbitration reimbursements [3][4] - After Nutex announced a delay in its Form 10-Q filing, shares plunged 16.39%, closing at $92.91 [6] Group 3: Financial Reporting Issues - The lawsuit asserts that Nutex misrepresented its progress in addressing internal control deficiencies, particularly in misclassifying stock-based compensation obligations [5] - On August 21, Nutex disclosed that its Audit Committee found prior financial statements required restatement due to incorrect classification of obligations [7] Group 4: Investor Impact - The class-action suit seeks damages for investors who acquired Nutex securities during the alleged misrepresentation period, claiming public disclosures were materially misleading [9] - Hagens Berman is investigating whether Nutex's business model relied on questionable arbitration tactics and if its financial reporting misled investors [10]

Core Viewpoint - A class action lawsuit has been filed against Nutex Health Inc. for allegedly making materially false and misleading statements regarding its business operations and financial prospects during the specified Class Period from August 8, 2024, to August 14, 2025 [8]. Allegation Details - The lawsuit claims that Nutex engaged in a scheme to defraud insurance companies through HaloMD, leading to unsustainable revenue [3]. - It is alleged that Nutex overstated its ability to remediate material weaknesses in its internal controls over financial reporting [3]. - The company reportedly misclassified stock-based compensation obligations, increasing the risk of failing to file timely financial reports with the SEC [3]. - Overall, the public statements made by Nutex were deemed materially false and misleading throughout the relevant period [3]. Next Steps - Investors who purchased Nutex shares and suffered losses are encouraged to contact the law firm for more information regarding their rights and potential claims [4]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is October 21, 2025 [8]. About the Law Firm - Bragar Eagel & Squire, P.C. is a recognized law firm specializing in representing individual and institutional investors in complex litigation [5].

Core Points - The Gross Law Firm has issued a notice to shareholders of Nutex Health Inc. regarding a class action lawsuit related to misleading statements and financial reporting issues [1][2] - The class period for the lawsuit is from August 8, 2024, to August 14, 2025, during which the company allegedly engaged in fraudulent activities through a third-party vendor, HaloMD [2] - Shareholders are encouraged to register for the class action by the deadline of October 21, 2025, to potentially become lead plaintiffs [3] Allegations Summary - The complaint alleges that Nutex Health Inc. made materially false and misleading statements, including the fraudulent conduct of HaloMD in defrauding insurance companies [2] - It is claimed that revenues from HaloMD's engagement were unsustainable due to the fraudulent nature of the activities [2] - The company reportedly overstated its ability to remediate weaknesses in its internal controls over financial reporting, leading to improper accounting of stock-based compensation obligations [2] Next Steps for Shareholders - Shareholders who purchased shares during the specified class period should register to receive updates and monitor the case's progress [3] - There is no cost or obligation for shareholders to participate in the class action [3] Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices [4] - The firm seeks recovery for investors who suffered losses due to false or misleading statements that inflated stock prices [4]